Literature DB >> 7717879

The detection of subchronic testicular damage using urinary creatine: studies with 2-methoxyethanol.

M Butterworth1, D Creasy, J A Timbrell.   

Abstract

We have previously shown that a number of testicular toxicants administered acutely to rats raise urinary creatine. The aim of this study was to determine if this creatinuria was maintained during subchronic testicular damage. Repeated exposure of rats to 2-methoxyethanol for 10 days administered in the drinking water caused significant testicular damage at the highest dose. The urinary creatine:creatine ratio was significantly increased in the animals receiving the highest dose (220 mg/kg per day) and also those receiving doses of 87 mg/kg per day. Increases in the ratio seen after the lowest dose (43 mg/kg per day) were significant in some cases, but showed more variability. Relative testicular weight was only significantly reduced after the highest dose. Increases in body weight over the time of exposure were only significantly lower after the highest dose of 2-methoxyethanol. The results indicate that urinary creatine may be a useful biomarker for chronic testicular damage.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7717879     DOI: 10.1007/s002040050160

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  10 in total

1.  Urinary creatine as a possible marker for testicular damage: studies with the testicular toxic compound 2-methoxyethanol.

Authors:  L Rawcliffe; D Creasy; J A Timbrell
Journal:  Reprod Toxicol       Date:  1989       Impact factor: 3.143

2.  [Toxicology of ethyleneglycol-monoethyl ether].

Authors:  E G Stenger; L Aeppli; D Müller; E Peheim; P Thomann
Journal:  Arzneimittelforschung       Date:  1971-06

3.  Comparative short-term inhalation toxicity of ethylene glycol monomethyl ether and propylene glycol monomethyl ether in rats and mouse.

Authors:  R R Miller; J A Ayres; L L Calhoun; J T Young; M J McKenna
Journal:  Toxicol Appl Pharmacol       Date:  1981-12       Impact factor: 4.219

4.  Studies on the relationship between acute testicular damage and urinary and plasma creatine concentration.

Authors:  J Gray; J K Nicholson; D M Creasy; J A Timbrell
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

5.  The morphological development of glycol ether-induced testicular atrophy in the rat.

Authors:  D M Creasy; P M Foster
Journal:  Exp Mol Pathol       Date:  1984-04       Impact factor: 3.362

6.  A quantitative study of stage-specific spermatocyte damage following administration of ethylene glycol monomethyl ether in the rat.

Authors:  D M Creasy; J C Flynn; T J Gray; W H Butler
Journal:  Exp Mol Pathol       Date:  1985-12       Impact factor: 3.362

7.  Testicular toxicity of ethylene glycol monomethyl and monoethyl ethers in the rat.

Authors:  P M Foster; D M Creasy; J R Foster; L V Thomas; M W Cook; S D Gangolli
Journal:  Toxicol Appl Pharmacol       Date:  1983-07       Impact factor: 4.219

8.  Urinary creatine profiles after administration of cell-specific testicular toxicants to the rat.

Authors:  N P Moore; D M Creasy; T J Gray; J A Timbrell
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

9.  Acute testicular toxicity of 1,3-dinitrobenzene and ethylene glycol monomethyl ether in the rat: evaluation of biochemical effect markers and hormonal responses.

Authors:  S C Reader; C Shingles; M D Stonard
Journal:  Fundam Appl Toxicol       Date:  1991-01

10.  [Testicular atrophy of mice induced by ethylene glycol mono alkyl ethers (author's transl)].

Authors:  K Nagano; E Nakayama; M Koyano; H Oobayashi; H Adachi; T Yamada
Journal:  Sangyo Igaku       Date:  1979-01
  10 in total
  1 in total

1.  SOT Symposium Highlight: Translatable Indicators of Testicular Toxicity: Inhibin B, MicroRNAs, and Sperm Signatures.

Authors:  Edward Dere; Linnea M Anderson; Michelle Coulson; Barry S McIntyre; Kim Boekelheide; Robert E Chapin
Journal:  Toxicol Sci       Date:  2013-09-19       Impact factor: 4.849

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.